Cassandra N Moore MD
Genitourinary Oncology
Senior Associate Consultant, Mayo Clinic
Join to view full profile
13400 E Shea BlvdScottsdale, AZ 85259
Dr. Moore is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cassandra Moore is an oncologist based in Scottsdale, AZ, with subspecialty expertise in genitourinary oncology. She completed her medical education at the University of New Mexico School of Medicine and pursued residency in internal medicine at UMass Chan Medical School followed by a fellowship in hematology and medical oncology at Duke University Hospital. Currently, she serves as a Senior Associate Consultant at Mayo Clinic Hospital, having previously been the Lead Physician at Banner MD Anderson Cancer Center. Dr. Moore is experienced in treating various genitourinary cancers, including prostate, kidney, bladder, and testicular cancer. She has contributed to several publications related to prostate cancer and participated in clinical trials such as the GEN1046 Safety Trial in patients with malignant solid tumors.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2006
UMass Chan Medical SchoolResidency, Internal Medicine, 1999 - 2002
University of New Mexico School of MedicineClass of 1999
Certifications & Licensure
GA State Medical License 2024 - 2028
TN State Medical License 2024 - 2028
CO State Medical License 2024 - 2027
LA State Medical License 2024 - 2027
MD State Medical License 2025 - 2027
MI State Medical License 2024 - 2027
NC State Medical License 2024 - 2027
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2013, 2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2017
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2013, 2017
Clinical Trials
- GEN1046 Safety Trial in Patients With Malignant Solid Tumors Start of enrollment: 2019 May 14
Publications & Presentations
PubMed
- Development of a prostate cancer survivorship care toolkit for Black men with clinical and contextual tailoring.Kimlin Ashing, Floyd Willis, Christopher Williams, James Morrison, John McCall
Supportive Care in Cancer. 2026-07-23 - Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors.Ibrahim M Asiri, Ronald C Chen, Viraj Master, Lanyu Mi, Sarah E James
Pharmacoepidemiology and Drug Safety. 2026-07-01 - 10 citationsThe impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, Ellen Jaeger, Elisa Ledet
The Prostate. 2022-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: